Amgen to Present New Data on Repatha and Cardiovas...
Category : Clinical Trial Update 4 November 2025Amgen announced that new data from its cardiovascular portfolio, including late-breaking results fro...
Newsletter - All News
Newsletter- All News is a comprehensive section of updated news and current trends, specifically curated to keep clinical trials, including breakthroughs in drug research, regulatory approvals, and advancements in study methodologies. Our news covers key trends in trial designs, patient recruitment strategies, and cutting-edge technologies shaping the future of clinical research
ENGULF Study Demonstrates Strong Safety and Effica...
Category : Clinical Trial Update 4 November 2025Results from the pivotal cohort of the ENGULF Investigational Device Exemption (IDE) study evaluatin...
New Findings on Transdermal Curcumin Gel Show Prom...
Category : Clinical Trial Update 4 November 2025Researchers will present new findings demonstrating that a novel transdermal curcumin gel (VAS-101;...
Gefurulimab Meets Primary and Secondary Endpoints...
Category : Clinical Trial Update 3 November 2025Positive topline results from the global PREVAIL Phase III trial showed that gefurulimab achieved bo...
GC Biopharma Publishes Phase 2 Results of World’s...
Category : Clinical Trial Update 3 November 2025Study demonstrates strong immunogenicity and favorable safety profile for BARYTHRAX inj. (GC1109)...
Latest Newsletter Post
-
New Findings on Transdermal Curcumi..
4 November 2025
-
ENGULF Study Demonstrates Strong Sa..
4 November 2025
-
Amgen to Present New Data on Repath..
4 November 2025
-
Otsuka Pharmaceutical Secures Exclu..
3 November 2025
-
GC Biopharma Publishes Phase 2 Resu..
3 November 2025
Subscribe to Our Newsletter!
C-89, Sector-65 Noida-U.P. 201301 (India)
Phone: +91-120-6631301-361
Mobile: +91-9990237670
Customer Care: 18004190155
Email: info@lifescienceintellipedia.com
Email: sales@lifescienceintellipedia.com